|
1 Halder RC，Aguilera C，Maricic I，et al. Type Ⅱ NKT cell-mediated anergy induction in type Ⅰ NKT cells prevents inflammatory liver disease [J]. J Clin Invest, 2007, 117(8): 2302-2312.
|
|
2 Bendelac A, Savage P B, Teyton L. The biology of NKT cells [J]. Annu Rev Immunol, 2007，25: 297-336.
|
|
3 Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family [J]. Nat Immunol, 2010, 11(3): 197-206.
|
|
4 Kronenberg M, Engel I. On the road：Progress in finding the unique pathway of invariant NKT cell differentiation [J]. Curr Opin Immunol, 2007, 19(2): 186-193.
|
|
5 Godfrey DI, Berzins SP. Control points in NKT2 cell development [J]. Nat Rev Immunol, 2007, 7(7): 505-518.
|
|
6 Yu KO, Im JS, Molano A, et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of (alpha1)-galacmsylceramides [J]. Proc Natl Aead Sci USA, 2005, 102(9): 3383-3338.
|
|
7 Ono éK, Yanagawa Y, Minami K, et al. Th1 or Th2 balance regulated by interaction between dendritic cells and NKT cells [J]. Immunol Res, 2007, 38 (1-3): 319-332.
|
|
8 Akbari O, Stock P, Meyer E, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergn-induced airway hyperreactivity[J]. Nat Med, 2003, 9(5): 582-588.
|
|
9 Meyer EH, Goya S, Akbari O, et al. Glycolipid activation of invariant T cell receptor ＋NKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4＋T cells [J]. Proc Natl Acad Sci USA, 2006, 103(8): 2782-2787.
|
|
10 Pichavant M, Goya S, Meyer EH, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17 [J]. J Exp Med, 2008, 205(2): 385-393.
|
|
11 Umetsu DT, Dekruyff RH. Natural killer T cells are important in the pathogenesis of asthma: The many pathways to asthma [J]. J Allergy Clin Immunol, 2010, 125(5): 975-979.
|
|
12 Stock P, Lombardi V, Kohlrautz V, et al. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB [J]. J Immunol, 2009, 182(8): 5116-5122.
|
|
13 Matsuda JL, Zhang Q, Ndonye R, et al. T-bet concomitantly controls migration, survival, and effector functions during the development of Vα14 iNKT cells[J]. Blood, 2006, 107(7): 2798 - 2805.
|
|
14 Kim HY, Pichavant M, Matangkasombut P, et al. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells[J]. J Immunol, 2009, 182(5): 3252-3261.
|
|
15 Akbari O, Faul JL, Hoyte EG, et al. CD4＋invariant T cell receptor＋ natural killer T cells in bronchial asthma [J]. N Engl J Med, 2006，354(11): 1117-1129.
|
|
16 Matangkasombut P, Marigowda G, Ervine A, et al. Natural killer T cells in the lungs of patients with asthma [J]. J Allergy Clin Immunol, 2009, 123(5): 1181-1185.
|
|
17 Koh YI, Shim JU, Wi JO, et al. Inverse association of peripheral blood CD4(＋) invariant natural killer T cells with atopy in human asthma[J]. Hum Immunol, 2010, 71(2): 186-191.
|
|
18 Vijayanand P，Seumois G，Pickard C，et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease[J]. N Engl J Med, 2007, 356(14): 1410-1422.
|
|
19 Thomas SY, Lilly CM, Luster AD. Invariant natural killer T cells in bronchial asthma [J]. N Engl J Med, 2006, 354(24): 2613-2616.
|
|
20 Mutalithas K, Croudace J, Guillen C, et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma [J]. J Allergy Clin Immunol, 2007, 119(5)：1274-1276.
|
|
21 Umetsu DT, Dekruyff RH. The regulatory role of natural killer T cells in the airways [J]. Int J Biochem Cell Biol, 2010, 42(4): 529-534.
|
|
22 Lombardi V，Stock P，Singh AK，et al. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity [J]. J Immunol, 2010, 184(4): 2107-2115.
|